Home
La Jolla Pharmaceutical Company Announced an Exclusive Licensing Agreement for GIAPREZA and XERAVA in Europe

La Jolla Pharmaceutical Company Announced an Exclusive Licensing Agreement for GIAPREZA and XERAVA in Europe

Today’s Highlights January 12, 2021

La Jolla Pharmaceutical Company Announced an Exclusive Licensing Agreement for GIAPREZA and XERAVA
La Jolla Pharmaceutical Company (LJPC) announced today in a press release that . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.
Today’s Highlights
,
January 12, 2021

Other Articles